Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/10/2024 | BLACKROCK INC. | 3.31 M | $4.17 M | -4.26% | 4.90% |
05/15/2024 | STATE STREET CORP | 826,581 | $1.04 M | 0.00% | 1.22% |
05/13/2024 | RENAISSANCE TECHNOLOGIES LLC | 824,700 | $1.04 M | 23.90% | 1.22% |
05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 754,110 | $950,178 | 4.08% | 1.12% |
05/03/2024 | GSA CAPITAL PARTNERS LLP | 493,571 | $622,000 | -9.31% | 0.73% |
05/14/2024 | NORTHERN TRUST CORP | 458,145 | $577,262 | -7.30% | 0.68% |
05/10/2024 | VANGUARD GROUP INC | 330,047 | $415,859 | 9.04% | 0.49% |
05/13/2024 | NUVEEN ASSET MANAGEMENT, LLC | 271,795 | $342,462 | 0.00% | 0.40% |
05/15/2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,790 | $231,575 | -11.97% | 0.27% |
04/25/2024 | BANK OF NEW YORK MELLON CORP | 173,206 | $218,240 | -2.96% | 0.26% |
05/15/2024 | MORGAN STANLEY | 173,071 | $218,069 | -30.63% | 0.26% |
05/20/2024 | VIRTU FINANCIAL LLC | 157,516 | $198,000 | 100.00% | 0.23% |
05/09/2024 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 153,561 | $193,487 | 0.00% | 0.23% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 114,560 | $144,345 | -43.60% | 0.17% |
05/15/2024 | GOLDMAN SACHS GROUP INC | 92,424 | $116,454 | -11.54% | 0.14% |
05/15/2024 | TWO SIGMA SECURITIES, LLC | 85,313 | $107,494 | 91.83% | 0.13% |
05/15/2024 | BARCLAYS PLC | 82,434 | $105,000 | -34.42% | 0.12% |
05/09/2024 | RHUMBLINE ADVISERS | 76,455 | $96,325 | 3.76% | 0.11% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 76,118 | $95,909 | -26.28% | 0.11% |
05/08/2024 | ORIN GREEN FINANCIAL, LLC | 72,000 | $90,720 | -10.00% | 0.11% |
05/13/2024 | UBS GROUP AG | 67,956 | $85,625 | -9.05% | 0.10% |
04/29/2024 | COMMONWEALTH EQUITY SERVICES, LLC | 50,100 | $63,000 | 100.00% | 0.07% |
05/15/2024 | HSBC HOLDINGS PLC | 46,680 | $58,817 | 16.51% | 0.07% |
05/07/2024 | NEW YORK STATE COMMON RETIREMENT FUND | 45,655 | $58,000 | 1.23% | 0.07% |
05/15/2024 | CITADEL ADVISORS LLC | 37,788 | $47,613 | 100.00% | 0.06% |
05/13/2024 | FRANKLIN RESOURCES INC | 33,548 | $42,270 | 0.00% | 0.05% |
05/13/2024 | AMERICAN INTERNATIONAL GROUP, INC. | 33,321 | $41,984 | 1.05% | 0.05% |
05/10/2024 | JPMORGAN CHASE & CO | 32,518 | $40,973 | -25.65% | 0.05% |
05/16/2024 | JANE STREET GROUP, LLC | 28,921 | $36,440 | 0.33% | 0.04% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 27,800 | $35,028 | -61.92% | 0.04% |
05/15/2024 | VOYA INVESTMENT MANAGEMENT LLC | 27,023 | $34,049 | -7.66% | 0.04% |
04/26/2024 | CAPITAL PERFORMANCE ADVISORS LLP | 26,258 | $33,085 | 1.09% | 0.04% |
05/14/2024 | INVESCO LTD. | 25,908 | $32,644 | -3.63% | 0.04% |
05/14/2024 | VERITION FUND MANAGEMENT LLC | 23,465 | $29,566 | 100.00% | 0.03% |
05/14/2024 | ALLIANCEBERNSTEIN L.P. | 23,400 | $29,484 | 0.00% | 0.03% |
05/10/2024 | WELLS FARGO & COMPANY/MN | 23,369 | $29,445 | 17.26% | 0.03% |
05/06/2024 | SG AMERICAS SECURITIES, LLC | 21,467 | $27,000 | -37.97% | 0.03% |
05/15/2024 | APTUS CAPITAL ADVISORS, LLC | 19,621 | $24,722 | 5.93% | 0.03% |
05/15/2024 | SQUAREPOINT OPS LLC | 17,815 | $22,447 | 100.00% | 0.03% |
05/15/2024 | KESTRA ADVISORY SERVICES, LLC | 16,000 | $20,160 | 39.13% | 0.02% |
05/15/2024 | PRICE T ROWE ASSOCIATES INC /MD/ | 15,982 | $21,000 | 0.00% | 0.02% |
05/15/2024 | LIDO ADVISORS, LLC | 15,554 | $19,598 | 0.00% | 0.02% |
05/15/2024 | CITADEL ADVISORS LLC | 12,800 | $16,128 | -83.94% | 0.02% |
05/10/2024 | CITIGROUP INC | 12,731 | $16,041 | 10.22% | 0.02% |
05/08/2024 | PROSHARE ADVISORS LLC | 12,147 | $15,306 | 10.64% | 0.02% |
05/15/2024 | ALTSHULER SHAHAM LTD | 12,142 | $15,299 | 0.00% | 0.02% |
05/15/2024 | MILLENNIUM MANAGEMENT LLC | 10,484 | $13,210 | 100.00% | 0.02% |
05/09/2024 | HARBOUR INVESTMENT MANAGEMENT LLC | 10,100 | $12,726 | 0.00% | 0.02% |
05/15/2024 | CITADEL ADVISORS LLC | 10,100 | $12,726 | -57.92% | 0.02% |
05/16/2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 6,797 | $8,564 | -37.75% | 0.01% |
A. During the previous two years, 86 institutional investors and hedge funds held shares of Protalix BioTherapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 3.31 M
STATE STREET CORP: 826,581
RENAISSANCE TECHNOLOGIES LLC: 824,700
GEODE CAPITAL MANAGEMENT, LLC: 754,110
GSA CAPITAL PARTNERS LLP: 493,571
NORTHERN TRUST CORP: 458,145
A. 13.99% of Protalix BioTherapeutics, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 15.27 M shares in the last 24 months. This purchase volume represents approximately $16.03 M in transactions.